The promising in vitro antibacterial activity of
HETROBACT (Mupirocin) against
- Gram-positive Staphylococci, including methicillin-resistant S. aureus, (MRSA), the main causative microorganism of skin infections, drives its widespread use in prophylaxis and treatment of infections associated with skin, skin appendages and mucosal membranes
- Gram-negative microorganisms such as Haemophilus influenzae and Neisseria spp.
HETROBACT (Mupirocin) is used in Conditions like Impetigo, Folliculitis, Furunculosis, Infected Eczema & Ecthyma.